- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Xebra Brands Appoints Jay Garnett as CEO
Xebra Brands Ltd. ("Xebra"), a cannabis company, is pleased to announce that Mr. Jay Garnett has been appointed Chief Executive Officer and Director.
Over his nearly 30-year career, he has been recognized with numerous business awards and accolades, including Profit 100's Top 100 in Canada five years in a row, BC Business Top 30 Under 30 and Top 40 Under 40, and he was a finalist for Ernest & Young's Entrepreneur of the Year.
"We are absolutely thrilled to have a CEO of Jay's caliber, and firmly believe that his experience and vision will take Xebra to the next level. He is uniquely skilled at developing brands and leading companies through the growth phase, and he has an exceptional track record of success," commented Xebra Founder and Chairman Robert Giustra.
"I'm elated to assume the helm of Xebra on the eve of the launch of its first commercial cannabis product, Vicious Citrus. My aim is to elevate Xebra's first mover status in Mexican CBD, Dutch pharma-grade THC, and CBN in Canada, to dominant market positions," commented Mr. Garnett.
Beyond the Scrubs: Understanding Healthcare Providers as People for Increased Engagement
March 28th 2024The benefits of adopting a humanized approach to healthcare provider marketing extend across the healthcare spectrum, enhancing engagement rates, brand loyalty, and marketing ROI, while also driving better outcomes for patients.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.
